
AI coding tools have fundamentally changed how software gets built. Developers are shipping more code, faster, with less friction than ever before. But the organizations benefiting most from AI-accelerated development are running into the same wall: quality hasn't kept pace.
More code means more surface area for bugs. More PRs means more review burden on senior engineers. More releases means more chances for regressions to reach customers. The bottleneck has moved from writing code to verifying it, and verification is still largely manual.
Checksum is a continuous quality platform built for this reality. Its suite of AI agents autonomously generates, runs, and maintains tests across every layer of the software development lifecycle: end-to-end UI flows, API endpoint coverage, and PR-level CI validation, so engineering teams can move fast without sacrificing reliability.
What sets Checksum apart: it doesn't wait for instructions. It works as a background agent, continuously monitoring your codebase, generating tests for what matters, and repairing broken tests as the product evolves. Seventy percent of test failures resolve automatically, eliminating the maintenance burden that causes most test suites to decay and get abandoned.
Every test Checksum produces is real, Playwright code you own, submitted as a PR to your repository. No vendor lock-in. Teams keep full control.
Checksum is fine-tuned on 1.5+ million test runs and integrates natively with Cursor, Claude Code, and 100+ AI coding agents via /checksum slash commands. Testing happens before code review, not after. Generation and healing run on Checksum's cloud, consuming no LLM tokens or local resources.
The bottom line: Checksum gives engineering teams the confidence to ship at the speed AI makes possible.
Learn more
Significantly improve the speed and quality of Radiology reporting by reducing unnecessary dictation, particularly for ultrasound and DEXA. Imorgon transfers modality measurements into Powerscribe/Fluency/RadAI merge fields/tokens, eliminating manual entry errors.
Imorgon's specialized services offer the following advantages:
- All measurements are always transferred (usually DICOM SR)
- Electronic worksheets capture findings and insert them into Powerscribe/Fluency/RadAI (rather than dictating from a worksheet)
- Worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- Integrate into Epic or other EHRs
- Vendor neutral
- Support to ensure everything continues working
Significant improvement in the overhead of reporting with a quick ROI.
Learn more
Merlin CardioMotion
Merlin's CardioMotionTM echo analysis and reporting software, distributed by CDN in Australia, transforms the approach to quickly diagnosing cardiac issues. It is specifically tailored for use in various medical environments such as emergency departments, CCUs, ICUs, oncology suites, medical center practitioners, ultrasound labs, cardiology sections, and even in rural or isolated areas where point-of-care devices are essential. Additionally, it offers significant benefits for cardiac monitoring in clinical trials. What distinguishes Merlin CardioMotionTM is its unique capability to accurately process slow frame rate echo clips without requiring an ECG trace for detection, thus making it usable with lower-end ultrasound machines. Utilizing advanced image processing technology, the software is grounded in proprietary algorithms that enable the automatic detection of the ventricular wall and its borders. This cutting-edge methodology facilitates a rapid and accurate quantitative assessment of the heart's dynamic performance, leading to improved patient care and outcomes. Consequently, healthcare providers are empowered to make better-informed decisions regarding cardiac health management, ultimately promoting a higher standard of patient well-being.
Learn more
Us2.ai
Us2.ai is transforming the fight against heart disease by leveraging AI-powered ultrasound software, making heart health services available to a broader audience. This groundbreaking platform offers 45 automated echo parameters, including strain analysis, and facilitates real-time interpretation of both 2D and Doppler images. It integrates effortlessly with any ultrasound machine, generating comprehensive reports without any user input, all while ensuring high accuracy that can be easily benchmarked against expert assessments. The AI echo copilot from Us2.ai independently evaluates all heart chambers using 2D and Doppler imaging, providing detailed, real-time reports that adhere to global reference guidelines. Recently, the software received FDA approval for Us2.v2, which continues to include the 45 automated echo parameters like strain analysis, marking a significant leap forward in healthcare innovation. Us2.ai aspires to democratize echocardiography, making ultrasound technology accessible to everyone, irrespective of their geographic or socioeconomic status, which is essential for enhancing heart health universally. This dedication to innovation and inclusivity places Us2.ai at the leading edge of the medical technology industry, promising a future where advanced heart care is within reach of all individuals.
Learn more